A carregar...
Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 (HER2) and p53 in Gastric Adenocarcinoma: A Pilot Study from Northern India
INTRODUCTION: After the recent approval of Trastuzumab (anti-HER2 antibody) for the treatment of HER2 overexpressed Gastric Adenocarcinoma (GA), importance of HER2 testing is increasingly recognized. However, there is paucity of studies for HER2 overexpression in the Indian patients of GA. Similarly...
Na minha lista:
Publicado no: | J Clin Diagn Res |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
JCDR Research and Publications (P) Limited
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5483674/ https://ncbi.nlm.nih.gov/pubmed/28658772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2017/25650.9921 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|